Product Information
MISOPROSTOL 200 MCG TABLET is a generic product labeled by GenBioPro, Inc., priced at $0.7189 per EA under NDC 43393002404. Its NADAC has been published 82 times since Mar 12, 2025.
FDA first approved this application on Jul 2, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 ug/1
Manufacturer
GenBioPro, Inc.NDC
43393002404
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MISOPROSTOLApproval Type
Generic (ANDA)
FDA Application
ANDA210201FDA Approved
7/2/2019
TE Code
AB
On Market Since
9/30/2024
Pharmacological Classes
Price Statistics
The NADAC for MISOPROSTOL 200 MCG TABLET has been published 82 times since Mar 12, 2025, and over the history we have for it it has risen 10.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7189 per EA |
|---|---|
| All-time high | $0.7414 (Aug 12, 2026) |
| All-time low | $0.6303 (Sep 17, 2025) |
| 52-week high | $0.7414 |
| 52-week low | $0.6303 |
| Median price | $0.6813 |
| Average price | $0.6811 |
| Largest weekly change | +6.1% (Apr 23, 2025) |
| Weeks tracked | 82 |
| Tracking since | Mar 12, 2025 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 20% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
GenBioPro, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Misoprostol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Prostaglandin E1 Analog class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MISOPROSTOL 200 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MISOPROSTOL 200 MCG TABLET, manufactured by GenBioPro, Inc., is $0.7189 per EA (NDC 43393002404), effective Sep 30, 2026.
How has the price of MISOPROSTOL 200 MCG TABLET changed over time?
Over the history we have for it, the NADAC for MISOPROSTOL 200 MCG TABLET has risen 10.6%. It has been tracked across 82 weekly CMS publications since Mar 12, 2025.
What are the highest and lowest recorded NADAC prices for MISOPROSTOL 200 MCG TABLET?
Since Mar 12, 2025, the NADAC for MISOPROSTOL 200 MCG TABLET has ranged from a low of $0.6303 (Sep 17, 2025) to a high of $0.7414 (Aug 12, 2026), with a median of $0.6813 per EA.
Are there cheaper alternatives to MISOPROSTOL 200 MCG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MISOPROSTOL 200 MCG TABLET, is $0.5784 per EA — about 20% below MISOPROSTOL 200 MCG TABLET.
Who manufactures MISOPROSTOL 200 MCG TABLET?
MISOPROSTOL 200 MCG TABLET (NDC 43393002404) is labeled by GenBioPro, Inc., and CMS classifies it as a generic product.